Astonea Labs Ltd (ASTONEALAB) is currently trading at 159.00 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.

Astonea Labs Ltd is focused on manufacturing and marketing pharmaceutical and cosmetic products, including antibiotics and multivitamins, used for skin, hair, and tooth care. The company also operates as a contract manufacturer for both domestic and international firms, highlighting its expansive operational reach. In recent strategic moves, Astonea Labs announced plans for a public issue of 27,90,000 Equity Shares, signaling potential growth and expansion. Astonea Labs markets its own products in India under the brands 'Glow Up' and 'Regero', showcasing its diversified product portfolio. The company has steadily expanded its production capabilities since 2019, indicating robust growth in its manufacturing operations.

Over the past 52 weeks, Astonea Labs Ltd has traded between a low of ₹118.00 and a high of ₹185.00. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.

Astonea Labs Ltd has a market capitalization of approximately 167.12. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.

Astonea Labs Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 22.91 and operates in the Pharmaceuticals sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.

Based on its market capitalization of 167.12 Cr, Astonea Labs Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.

Astonea Labs Ltd operates in the Pharmaceuticals sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.

The Price-to-Earnings (PE) ratio of Astonea Labs Ltd is 22.91. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.